Immunic Inc Sustainability Reports
Immunic, Inc. is a clinical-stage biotechnology company focused on developing a pipeline of selective oral immunology therapies. The company primarily targets chronic inflammatory and autoimmune diseases, such as multiple sclerosis and psoriasis.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300R5T12FW5MEQB20
FIGI: BBG001V10N36
4 reports from 2019 to 2024
